Advanced CT-based cardiac diagnostics software for assessing the hemodynamic significance of coronary lesions.
AI-powered ECG monitoring solutions for clinical trials focused on cardiac safety, compliance, and data accuracy.
Medical technology R&D focused on AI, cardiovascular disease diagnosis, and next-generation diagnostic solutions.
In 2011, the Company’s shares debuted on the NewConnect market, an alternative trading system outside the regulated market operated by the Warsaw Stock Exchange. Since February 3, 2014, Medicalgorithmics SA shares have been listed on the regulated market of the Warsaw Stock Exchange.
| Company name | MEDICALGORITHMICS |
| Ticker | MDG |
| ISIN | PLMDCLG00015 |
| Quotation market | BASIC |
| Sector | SERVICE |
| Indexes | WIG, WIG-POLAND, sWIG40 |
| Issued shares | 9 952 769 |
About us
Our History
Management Team
Partners
Work with us
Job offers
Recommend an employee
Application form